Mackay Shields LLC’s Xtrackers Harvest CSI 300 China A-Shares ETF ASHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-31,274
Closed -$1.03M 283
2022
Q1
$1.03M Buy
31,274
+939
+3% +$33.7K 0.01% 628
2021
Q4
$1.19M Buy
30,335
+1,655
+6% +$64.2K 0.01% 615
2021
Q3
$1.09M Buy
28,680
+360
+1% +$13.9K 0.01% 607
2021
Q2
$1.15M Buy
28,320
+9,920
+54% +$395K 0.01% 602
2021
Q1
$711K Sell
18,400
-133,294
-88% -$5.56M 0.01% 1104
2020
Q4
$6.08M Buy
151,694
+20,768
+16% +$779K 0.04% 437
2020
Q3
$4.51M Buy
130,926
+26,127
+25% +$897K 0.03% 468
2020
Q2
$3.11M Sell
104,799
-11,046
-10% -$305K 0.02% 565
2020
Q1
$3M Buy
115,845
+53,400
+86% +$1.51M 0.03% 504
2019
Q4
$1.85M Sell
62,445
-11,007
-15% -$310K 0.01% 900
2019
Q3
$1.99M Buy
+73,452
New +$2.02M 0.01% 903
2019
Q2
Sell
-88,781
Closed -$2.55M 1407
2019
Q1
$2.55M Buy
+88,781
New +$2.27M 0.02% 633

Other funds holding ASHR

Mackay Shields LLC's ASHR Position: Q2 2022 in Review

Mackay Shields LLC sold out of Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR) in Q2 2022, closing a stake of 31,274 shares — an estimated $1.03M sold.

Mackay Shields LLC first reported a position in ASHR in Q1 2019 and held it in 12 quarters. The position peaked at $6.08M in Q4 2020. 151 funds tracked by Wall St. Rank hold ASHR as of Q2 2022.

  • Mackay Shields LLC reported no remaining Xtrackers Harvest CSI 300 China A-Shares ETF position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 31,274 Xtrackers Harvest CSI 300 China A-Shares ETF shares in Q2 2022, an estimated $1.03M.
  • Mackay Shields LLC first reported a position in Xtrackers Harvest CSI 300 China A-Shares ETF in Q1 2019 and held it in 12 quarters.
  • Mackay Shields LLC's Xtrackers Harvest CSI 300 China A-Shares ETF position peaked at $6.08M in Q4 2020.
  • 151 funds tracked by Wall St. Rank held Xtrackers Harvest CSI 300 China A-Shares ETF as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.